Pasithea Therapeutics Corp.

NASDAQ (USD): Pasithea Therapeutics Corp. (KTTA)

Last Price

3.30

Today's Change

-0.12 (3.50%)

Day's Change

3.30 - 3.45

Trading Volume

8,111

Profile
KTTA

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Tiago Reis Marques M.D., Ph.D. Dr. Tiago Reis Marques M.D., Ph.D.

Full Time Employees:  8 8

IPO Date:  2021-09-15 2021-09-15

CIK:  0001841330 0001841330

ISIN:  US70261F2020 US70261F2020

CUSIP:  70261F103 70261F103

Beta:  0.82 0.82

Last Dividend:  0.00 0.00

Dcf Diff:  -8.52 -8.52

Dcf:  13.25 13.25

Description

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Address

1111 Lincoln Road,
Miami Beach, FL 33139, US

702 514 4174

http://www.pasithea.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment